Companies
Kemin
an Iowa-based animal-nutrition company supplying silage inoculants (Kem LAC line) built on Lactobacillus and Lacticaseibacillus strains that improve the fermentation and aerobic stability of maize silage.
- Country
- United States
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| agri-inputs-biocontrol | ✓ | ✓ | ✓ |
Regulatorsepaefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Production site | Kemin operates 17 manufacturing facilities globally, including sites in Belgium, Brazil, China, Egypt, India, Italy, San Marino, Singapore, South Africa, and the United States | businessrecord.com · prnewswire.com |
| Headcount | More than 3,000 employees globally | businessrecord.com · prnewswire.com |
| Revenue | $1 billion as of 2023 | businessrecord.com |
| Certification | FSSC 22000, FAMI-QS, and ISO 17025 accredited lab (North American facilities) | kemin.com |
| Regulatory approval | Compliance with FDA, USDA, and FSMA regulations; some products require specific governmental approval in certain countries | kemin.com |
Independent sources: businessrecord.com · prnewswire.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Liquid biopreparations for silage | agri-inputs-biocontrol | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.